Although large patient cohorts have been subjected to exom-wide mutational analyses, only a limited number of genes other than VHL and polybromo 1 (PBRM1) have been identified to have mutations in RCC, and most with low frequency [14]. Here, PBRM1 is linked to renal cell adenocarcinoma.